Literature DB >> 24456380

Measures of the electrically evoked compound action potential threshold and slope in HiRes 90K(TM) users.

Antoine Nehmé, Elie El Zir, Nabil Moukarzel, Hassan Haidar, Filiep Vanpoucke, Laure Arnold.   

Abstract

OBJECTIVES: To investigate electrically evoked compound action potentials (eCAPs) measured with the neural response imaging (NRI) 'SmartNRI' algorithm. NRI thresholds and slopes were examined according to three aspects: (1) site along the cochlea, (2) development of responses over time, and (3) influence of age/duration of deafness.
METHODS: Thirty-four individuals implanted with the Advanced Bionics HiRes 90K(TM) device were included. The eCAP recordings were made from four electrodes along the array at first fitting and at frequent intervals up to at least 2 years. Slope and threshold (tNRI) of the amplitude growth function were measured and a range of explanatory variables were tested for significant effects on these measures using multi-factorial analysis of variance.
RESULTS: Electrode position emerged as a significant effect for the tNRI measure, with lowest thresholds at the apical end of the array. Mean slope was greatest for the most apical electrode, but not significantly. Slope was significantly influenced by onset of deafness, with congenital hearing loss associated with steeper slopes than acquired hearing loss. There was also a highly significant effect of duration of device use, with a gradual increase in slope over the 2 years following device activation. DISCUSSION: The observed effects of electrode position are consistent with a model in which eCAP threshold is governed primarily by an effect of distance between electrode and neural interface (which is shorter towards the apex of the cochlea) and in which slope is governed primarily by density of surviving neural elements.

Entities:  

Keywords:  Cochlear implant, Neural response, Electrically evoked compound action potential, eCAP, Growth function, NRI, SmartNRI, HiRes 90K

Mesh:

Year:  2014        PMID: 24456380     DOI: 10.1179/1754762813Y.0000000039

Source DB:  PubMed          Journal:  Cochlear Implants Int        ISSN: 1467-0100


  6 in total

1.  Effects of Electrode Location on Estimates of Neural Health in Humans with Cochlear Implants.

Authors:  Kara C Schvartz-Leyzac; Timothy A Holden; Teresa A Zwolan; H Alexander Arts; Jill B Firszt; Christopher J Buswinka; Bryan E Pfingst
Journal:  J Assoc Res Otolaryngol       Date:  2020-04-27

2.  Across-site patterns of electrically evoked compound action potential amplitude-growth functions in multichannel cochlear implant recipients and the effects of the interphase gap.

Authors:  Kara C Schvartz-Leyzac; Bryan E Pfingst
Journal:  Hear Res       Date:  2016-08-10       Impact factor: 3.208

3.  Responsiveness of the Electrically Stimulated Cochlear Nerve in Children With Cochlear Nerve Deficiency.

Authors:  Shuman He; Bahar S Shahsavarani; Tyler C McFayden; Haibo Wang; Katherine E Gill; Lei Xu; Xiuhua Chao; Jianfen Luo; Ruijie Wang; Nancy He
Journal:  Ear Hear       Date:  2018 Mar/Apr       Impact factor: 3.570

4.  A Broadly Applicable Method for Characterizing the Slope of the Electrically Evoked Compound Action Potential Amplitude Growth Function.

Authors:  Jeffrey Skidmore; Dyan Ramekers; Deborah J Colesa; Kara C Schvartz-Leyzac; Bryan E Pfingst; Shuman He
Journal:  Ear Hear       Date:  2022 Jan/Feb       Impact factor: 3.562

5.  Polarity Sensitivity of Human Auditory Nerve Fibers Based on Pulse Shape, Cochlear Implant Stimulation Strategy and Array.

Authors:  Amirreza Heshmat; Sogand Sajedi; Anneliese Schrott-Fischer; Frank Rattay
Journal:  Front Neurosci       Date:  2021-12-08       Impact factor: 4.677

6.  The Evoked Compound Action Potential as a Predictor for Perception in Chronic Pain Patients: Tools for Automatic Spinal Cord Stimulator Programming and Control.

Authors:  Julie G Pilitsis; Krishnan V Chakravarthy; Andrew J Will; Karen C Trutnau; Kristin N Hageman; David A Dinsmoor; Leonid M Litvak
Journal:  Front Neurosci       Date:  2021-07-12       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.